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Abstract
Background: The splenic cysts constitute a very rare clinical entity. They may occur secondary
to trauma or even being more seldom due to parasitic infestations, mainly caused by ecchinocccus
granulosus. Literature lacks a defined concencus including the treatment plans and follow up
strategies, nor long term results of the patients. In the current study, we aimed to evaluate the
diagnosis, management of patients with parasitic and non-parasitic splenic cysts together with their
long term follow up progresses.
Methods: Twenty-four patients with splenic cysts have undergone surgery in our department over
the last 9 years. Data from eighteen of the twenty-four patients were collected prospectively, while
data from six were retrospectively collected. All patients were assessed in terms of age, gender,
hospital stay, preoperative diagnosis, additional disease, serology, ultrasonography, computed
tomography (CT), cyst recurrences and treatment.
Results: In this study, the majority of patients presented with abdominal discomfort and palpable
swelling in the left hypochondrium. All patients were operated on electively. The patients included
14 female and 10 male patients, with a mean age of 44.77 years (range 20–62). Splenic hydatid cysts
were present in 16 patients, one of whom also had liver hydatid cysts (6.25%). Four other patients
were operated on for a simple cyst (16%) two patients for an epithelial cyst, and the last two for
splenic lymphangioma. Of the 16 patients diagnosed as having splenic hydatit cysts, 11 (68.7%) were
correctly diagnosed. Only two of these patients were administered benzimidazole therapy pre-
operatively because of the risk of multicystic disease The mean follow-up period was 64 months
(6–108). There were no recurrences of splenic cysts.
Conclusion: Surgeons should keep in mind the possibility of a parasitic cyst when no definitive
alternative diagnosis can be made. In the treatment of splenic hydatidosis, benzimidazole therapy is
not necessary, although it is crucial to perform splenectomy without rupturing and spilling the cysts.
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Background
Cystic disease of the spleen is an uncommon condition
with an incidence of 0.07% in a review of over 42,000
autopsies [1]. The majority of cases are due to parasitic
infection with Echinococcus granulosus resulting in
hydatid disease [1,2]. Non-parasitic cysts account for less
than one-third of all splenic cyst cases, and the majority of
these are pseudo cysts secondary to trauma, with no epi-
thelial lining. True non-parasitic splenic cysts make up
only 10% of all benign non-parasitic splenic cysts and is
rarely clinically observed [1-3]. In the literature, there are
few studies on splenic cysts that show the details of diag-
nosis and have long term follow-up. In this study, we
present the management of splenic cysts in 24 patients at
our clinic and discuss the difficulties in classifying para-
sitic and nonparasitic cysts.
Methods
The records of 18 out of 24 patients who underwent sur-
gery for spleen cysts at our hospital during the period
from January 1999 to December 2008 were prospectively
analyzed. The records of the remaining 6 patients, who
were operated by the same surgical team, were retrospec-
tively analyzed. Then, after all the hospital records had
been examined, the patients were recalled to our hospital
one by one. Our exclusion criteria were multiple hydati-
dosis, and patients treated with percutaneous or laparo-
scopic management. All patients had splenectomy as the
procedure of choice and the splenectomies were all per-
formed by the same surgical team. All patients were vacci-
nated against Pneumococcus and Haemophilus
influenzae before surgery (2 weeks prior).
The analyses focused on the differentiated diagnosis of
splenic cysts and their treatment. In patients followed pro-
spectively, the variables recorded were age, gender, cyst
size, serology, mortality, morbidty and whether the dis-
ease was new or recurrent. Our retrospectively examined
patients were assessed with the same parameters. An Echi-
nococcus granulosus infection was diagnosed by imaging
procedures [ultrasonography and computed tomography
(CT)], serologic tests [indirect hemaglutination test
(IHA)], and an enzyme-linked immunosorbent assay
(ELISA).
Of the 18 prospectively observed patients, 2 received peri-
operative anthelmintic therapy because of their multi-
cystic state. Each of these patients received albendazole,
administered at a dose of 10 mg/kg body weight per day,
from 1 week before surgery to 4 months postoperatively.
During anthelmintic treatment, clinical examination and
laboratory work were performed each month. The blood
tests included a blood count, liver enzymes, and bilirubin
assay. The other 16 patients did not undergo any antihel-
mitic therapy. The study plan was reviewed and approved
by our institutional ethical committee, and an informed
consent was obtained for all patients
Results
This study included 24 patients, 18 of whom were
assessed prospectively, and 6 whose hospital records and
treatment information were examined retrospectively. All
six patients were recalled to our hospital and diagnosed as
having either hydatid (4 of 6) or simple splenic cysts (the
other 2). By CT and ultrasonography all 6 patients were re-
examined and found to have no recurrence. The mean age
of all these patients was 44.7 (range 20–62). Of the 24
patients, the number whose preoperative diagnoses was
defined as parasitic 19 (79.1%), where the serologies of
these patients were all positive. Four out of six patients
were diagnosed as having a hydatid cyst Ultrasonography
was successful in diagnosing the cystic lesions in all of
them, while the serology findings were positive in only
11. A CT scan that was done in 24 patients showed a cystic
lesion in all 24 (Fig. 1A, B, C). The size of the splenic cyst
varied from 6 to 15 cm. The spleen was the only site of the
hydatid in 14 patients (73%). An associated liver hydatid
was present in 2 patients including one with renal
involvement. The diagnosis of splenic parasitic cyst was
confirmed in all cases by histopathology on the basis of
resected specimens (Fig 2A, B, C). The most common
symptoms among those operated on electively were vague
abdominal pain or discomfort and/or a palpable mass in
the left hypochondrium (Fig 3).
The mean hospital stay was 5.8 days with a range of 4–12
days. The mean follow-up was 64.4 months, with a range
of 6 months to 108 months. None of the patients demon-
CT view of the different cyst Figure 1
CT view of the different cyst. A) Cystic lenfangiomas B) 
Epidermoid cyst C) Cyst hidatic.BMC Surgery 2009, 9:9 http://www.biomedcentral.com/1471-2482/9/9
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strated recurrence during the follow-up. No patient had
any serious septic complications. All the data are dis-
played in tables 1 and 2.
Discussion
Parasitic and non-parasitic cysts of the spleen have a very
similar clinical presentation, but due to their differences
in diagnosis and treatment, it is important to distinguish
the two. The majority of splenic cysts, both parasitic and
non-parasitic, are found incidentally on imaging [4].
Splenic cysts grow slowly and are characterized by a long
period of asymptomatic latency, such that initial diagno-
sis is usually established during the course of investiga-
tions carried out for other diseases. When the cyst reaches
a considerable size, its clinical presentation is normally a
result of pressure on adjacent viscera, and may include
renal arterial compression with systemic hypertension,
rupture to other organs, spontaneous cutaneous fistuliza-
tion, or segmental portal hypertension. However, mild
discomfort and pain in the left upper quadrant are the
most common complaints [5]. Splenic hydatidosis can be
diagnosed preoperatively with radiologic studies [4].
However, sonographic and CT findings of splenic hydati-
dosis are not specific, and other splenic cystic lesions, such
as an epidermoid cyst, splenic abscess, a pseudocyst, or a
cystic neoplasm of the spleen, may present with a similar
appearance. The differential diagnosis is greatly helped by
the history, the presence of calcification in the cyst wall,
the presence of daughter cysts in a large cystic lesion or
concominant cystic lesions in the liver or other organs
[5,6]. In patients with negative serology and indetermi-
nant US and CT examinations, it may be helpful to use
MRI. A recent article [6] has shown the value of MRI in dif-
ferentiating parasitic, nonparasitic, traumatic or other
unilocular cyst by demonstrating: "A low-signal intensity
rim so-called rim sign, can be seen on both T1 & T2
weighted MR images but more conspicuous or evident on
T2 weighted images, has been described as characteristic
of hydatidosis as opposed to nonparasitic cysts in the liver
and lungs. The low intensity rim represents the fibrous
collagenous pericyst with or without calcifications. How-
ever, this sign is a nonspecific sign or finding as it can be
also seen in amebic abscess, hematoma, and hepatocellu-
lar carcinoma of the liver. Furthermore, the newer appli-
cations of functional MRI (MR Diffusion & MR
Spectroscopy) can help to differentiate between parasitic
versus non-parasitic splenic cysts"[6].
In this study, there were no problems observed in patients
preoperatively diagnosed clearly as parasitic or non para-
sitic. The major problem was with those cases that could
not be differentiated as parasitic or non-parasitic by imag-
ing and the serologies negative. There were no differences
between labarotory findings and CT or USG images in
these cases. The diagnoses were made intraoperatively or
postoperatively by pathological examination. All postop-
eratively-diagnosed patients had hydatid cysts belonging
to Gharbi level I (Fig 2A, B, C).
As seen here, diagnostic confusion was related to the type
of the hydatid cysts. In the clinical setting, the pre-opera-
tive diagnosis of splenic cysts is of significance because the
treatment of splenic cysts has changed over the years to a
more conservative approach [6-10]. Due to the increased
use of laparoscopic techniques, the recurrence of hyda-
tidic disease resulting from spillage of cystic fluid during
carelessly-performed operations may increase [8]. The
classic approach to splenic cysts has been total splenec-
tomy. However, the risk of overwhelming postsplenec-
tomy sepsis has led to the development of paranchyma-
preserving surgical procedures [11]. In recent years, percu-
Histopathological view of the splenic cyst Figure 2
Histopathological view of the splenic cyst. A)cystic len-
fangiomas B) psoudocyst C) cyst hydatic.
Intraoperative view of the cystic lenfangiomas in the spleen Figure 3
Intraoperative view of the cystic lenfangiomas in the 
spleen.BMC Surgery 2009, 9:9 http://www.biomedcentral.com/1471-2482/9/9
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taneous drainage of the splenic hydatid cyst with injection
and consecutive reaspiration of a scolocidal agent (PAIR
technique) has been proposed as an alternative, non-sur-
gical therapy for patients at high anesthetic risk or who do
not consent to surgery [5]. The high risk of septic compli-
cations caused the major change in the approach to spleen
surgery.
The basic measures to prevent the recurrence of hydatid
cysts include the reduction of their viability by using
drugs, the prevention of cystic fluid spillage and the com-
plete removal of their germinative membranes, which is
achieved by splenectomy [12,13]. Benzimidazole car-
bamates (mebandazole and albendazole) are antihelmin-
thic drugs that kill the parasite by impairing its glucose
uptake [14-16]. Although albendazole reaches a high
blood concentration after oral administration, cystic fluid
concentration of the drug is low and clinical outcome is
unpredictable [16,17]. The efficacy of preoperative alben-
dazole treatment was established by Wen et al [18]. Pre-
operative treatment with a benzimidazole drug should
begin at least four days before surgery (WHO Informal
Working Group on Echinococcosis,1996). In current prac-
tice, indications for benzimidazole therapy used in the
treatment of hydatid disease are inoperable primary
hepatic hydatic hydatidosis, multiple cysts in two or more
organs, multiple small liver cysts, cysts located deep in the
hepatic parenchyma, prevention and management of sec-
ondary hydatidosis, management of recurrent hydatido-
sis, unilocular cysts in unfit elderly patients, adjuvant
therapy with surgery or percutaneous interventions, pul-
monary echinococcosis, and long-term treatment for
cystic echinococcosis in specific organs like the bone,
brain, or eye [19]. Four different goals can be pursued
with medical management: definite cure, reduction of cyst
viability, preoperative treatment, and perioperative
prophylaxis. Definitive cure of univesicular cysts requires
a 3- to 6-month course of medication. Reduction in the
viability of the cysts can be achieved in multivesicular
cysts and preoperatively in univesicular cysts when percu-
taneous or elective surgery is planned [14]. There are only
a few papers about the preoperative or perioperative ster-
ilization of hydatid cysts [20]. However, the reported evi-
dence suggests that these drugs act principally
parasitostatically and not as parasiticides because the dis-
ease recurs when the drugs are discontinued [21]. This
means that they cannot cure the patient. However, there
are case reports regarding possible parasiticidal effects fol-
lowing long term chemotherapy. Hence, the real efficacy
of the benzimidazoles have not been entirely determined
Table 1: Prospective patients detail
Age
n = 18




Cyst recurrence Follow 
up(month)
50 F 6 6.6 +(liver hydatid) + USG _ 108
23 F 6 9 _ + CT+USG _ 90
46 F 5 9 _ + USG _ 85
38 F 7 8 _ + CT+USG _ 6
52 F 6 12 _ + CT+USG _ 14
34 F 4 16 _ + CT+USG _ 20
49 F 6 9.5 _ _ CT+USG _ 30
62 F 12 20 _ + CT+USG _ 45
33 F 6 10 _ + CT+USG _ 48
38 F 5 8 _ + CT+USG _ 75
25 M 5 9 _ + CT+USG _ 86
28 M 5 8.5 _ + CT+USG _ 54
43 M 7 6 _ + CT+USG _ 76
56 M 7 10 _ _ CT+USG _ 75
60 M 9 7.5 _ _ CT+USG _ 80
Table 2: Retrospective patiens detail
Age
n = 6
Gender Hosp. stay Cyst size Additional disease Serology Diagnostic studies Cyst recurrence
60 F 6 6.8 +(kidney hydatid) _ USG _
20 F 6 9 _ + CT+USG _
45 F 5 9 _ _ USG _
34 F 7 8 _ _ CT+USG _
54 M 6 12 _ _ CT+USG _
35 M 4 16 _ _ CT+USG _BMC Surgery 2009, 9:9 http://www.biomedcentral.com/1471-2482/9/9
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[22]. Moreover, Monterola et al. reported that the preop-
erative regimen for sterilising cysts was only 40% effective.
They also reported that there was no association between
the concentration of albendazole in the hydatid fluid and
viability of the scolices [23].
With respect to splenic hydatic cysts, Ahmad et al. main-
tained that splenectomy remains the procedure of choice
in cases of splenic hydatidosis and that benzimidazole
therapy has been proven to be effective in preventing the
recurrence of hydatid disease [24]. A point that needs to
be discussed here is whether postoperative anti-parasitic
treatment is required. In the literature, there are few stud-
ies concerning this issue [25-28]. Although not proven sci-
entifically, benzimidizole therapy for the treatment of
splenic cysts is still in practice. In our study we did not use
benzimidizole therapy in any of our cases and did not
confront any recurrences in the mean seven-year follow-
up. We chose not to use this drug because we believed we
had completely eradicated the hydatid cysts using splenec-
tomy. Now, there is a question that comes to mind:
Should postoperative anti-parasitic treatment be routinely
used even after splenectomy because of hydatid disease?
This question needs further prospective, randomized
studies. Our results show that if the surgeon totally excises
the splenic cyst, and there is no spillage into operative
area, it is possible to avoid use of benzimidazole therapy
after the operation.
Conclusion
Despite the advances in medical technology, it continues
to be hard to differentiate between parasitic and non-par-
asitic splenic cysts. Patients in whom this differentiation
cannot be made should be considered to have a parasitic
cyst and the operation should proceed accordingly. Even
though the efficacy of benzimidazole in splenic hydatid
has not been proven, it is an option depending on intra-
operative conditions. Therefore, the surgeon should keep
in mind the probability of a parasitic cyst when no differ-
entiation of splenic cysts can be made. In addition, in the
treatment of the splenic hydatidosis, benzimidazole ther-
apy may or may not be used, but it is vital that splenec-
tomy is performed without any spillage of the cyst
contents.
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